Wire Stories

Takeda Announces Positive Results in Phase 2b Study of Investigational TAK-279, an Oral, Once-Daily TYK2 Inhibitor, in People with Moderate-to-Severe Plaque Psoriasis

Results for TAK-279 (Formerly NDI-034858) Show a Significantly Greater Proportion of Patients Achieved Psoriasis Area and Severity Index (PASI) 75…

3 years ago

MOGU Announces Resignation and Appointment of Chief Executive Officer

HANGZHOU, China--(BUSINESS WIRE)--MOGU Inc. (NYSE: MOGU) (�MOGU� or the �Company�), a KOL-driven online fashion and lifestyle destination in China, announced…

3 years ago

Rocket Lab to Launch Pair of Satellites for BlackSky from New Zealand Just Days After Successful Launch from Virginia

The mission, Rocket Lab�s 8th mission for BlackSky Global, is scheduled to lift-off from Launch Complex 1 in New Zealand…

3 years ago

Connect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions

ePoster and Oral Presentation at American Academy of Dermatology Annual Meeting SAN DIEGO & TAICANG, China & SUZHOU, China--(BUSINESS WIRE)--Connect…

3 years ago

NEW YORK & GENEVA--(BUSINESS WIRE)--Recognizing the intersecting relationship between innovation, technology, the digital space and gender inequality, the Women�s Entrepreneurship…

3 years ago

DermaSensor Unveils Study Results Demonstrating Ability to Detect Skin Cancer With Device Granted FDA Breakthrough Designation

Presented at the American Academy of Dermatology (AAD) 2023 Annual Meeting, the FDA-submitted studies mark the first successful pivotal clinical…

3 years ago

DermaSensor Unveils Study Results Demonstrating Ability to Detect Skin Cancer With Device Granted FDA Breakthrough Designation

Presented at the American Academy of Dermatology (AAD) 2023 Annual Meeting, the FDA-submitted studies mark the first successful pivotal clinical…

3 years ago

DermaSensor Unveils Study Results Demonstrating Ability to Detect Skin Cancer With Device Granted FDA Breakthrough Designation

Presented at the American Academy of Dermatology (AAD) 2023 Annual Meeting, the FDA-submitted studies mark the first successful pivotal clinical…

3 years ago

DermaSensor Unveils Study Results Demonstrating Ability to Detect Skin Cancer With Device Granted FDA Breakthrough Designation

Presented at the American Academy of Dermatology (AAD) 2023 Annual Meeting, the FDA-submitted studies mark the first successful pivotal clinical…

3 years ago

AM Best Affirms Credit Ratings of Nan Shan General Insurance Co., Ltd.

HONG KONG--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of…

3 years ago
Show more Posts
Show previous Posts